June 4, 2024
CellCarta offers a full range of validated proteomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team of experts will guide and customize multiplexed assays to meet clinical trial needs, recommending the most appropriate path to validate assays, single plex and mutliplex.
Contact us for any custom development or assay validation.
You might also be interested by
Posters
Tumor-specific MHC class II upregulation associated with response to anti-PD-L1 therapy in patients with urothelial cancer
May 28, 2024
More infoCellTalk Blog
How CellEngine's LIMS integration led to time saving and more reliable data
May 22, 2024
More info